The Serum Institute of India (SII) has inaugurated its new unit in Pune. At over 2 million square feet, the plant has been designed to produce up to 500 million doses of vaccines in a year over the next three years.
This is the world’s largest multifunctional product facility which is in compliance with the vaccine manufacturing regulations of American and European markets.
This facility would export to about 150 countries and will help increase the company’s market share by 10-15 per cent internationally.
According to Adar Poonawalla, CEO, Serum Institute of India, the company had invested over Rs 3,000 crore towards the plant so far, and this would go up to Rs 4,000 crore and help create over 3,000 jobs over the next five years. SII currently produces about 1.5 billion doses a year, 70 per cent of which are exported.
Image Credit : www.pharmaceutical-tech.com